April « 2022 « Science and Enterprise

Health Blockchain Start-Up Raises $5.5M in Seed Funds

By Alan, on April 21st, 2022%

A new enterprise aggregating and securing a wide range of health care data with blockchain technology is raising $5.5 million in seed funds. . . . → Read More: Health Blockchain Start-Up Raises $5.5M in Seed Funds

Trial Begins Testing Crispr Gut Microbiome Therapy

By Alan, on April 20th, 2022%

A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers. . . . → Read More: Trial Begins Testing Crispr Gut Microbiome Therapy

Cystic Fibrosis Start-Up Raises $111M in New Funds

By Alan, on April 19th, 2022%

A developer of new treatments for the inherited lung disease cystic fibrosis emerged from stealth mode, raising $111 million in new venture funds. . . . → Read More: Cystic Fibrosis Start-Up Raises $111M in New Funds

Trial Set for Gut Infection Biologic Treatment

By Alan, on April 18th, 2022%

A developer of biologic therapies for gastrointestinal disorders says FDA cleared its request for a clinical trial testing its treatment for C. difficile. . . . → Read More: Trial Set for Gut Infection Biologic Treatment

Infographic – Chill Descends on Q1 Venture Funds

By Alan, on April 16th, 2022%

The rise in venture funds invested in start-up businesses worldwide over the past two years took a noticeable downturn in the first three months of 2022. . . . → Read More: Infographic – Chill Descends on Q1 Venture Funds

Biotech Start-Up Begins Longevity Therapy Work

By Alan, on April 15th, 2022%

A new biotechnology company has begun developing gene therapies aimed at reprogramming cells damaged by the aging process. . . . → Read More: Biotech Start-Up Begins Longevity Therapy Work

Gates Funds Engineered Malaria Mosquito Pilot Test

By Alan, on April 14th, 2022%

A developer of genetically altered insects designed to destroy disease-spreading colonies is set to begin pilot tests of its anti-malarial mosquito line. . . . → Read More: Gates Funds Engineered Malaria Mosquito Pilot Test

Preclinical Tests Show Antibody Stops Covid-19 Variants

By Alan, on April 13th, 2022%

Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2. . . . → Read More: Preclinical Tests Show Antibody Stops Covid-19 Variants

Synthetic Bio Companies Partner on Therapeutic Microbes

By Alan, on April 12th, 2022%

A developer of therapies from engineered microbes is collaborating with a synthetic biology components company on tools to create engineered gut bacteria. . . . → Read More: Synthetic Bio Companies Partner on Therapeutic Microbes

Natural Killer Cells Stop Ovarian Cancer in Preclinical Test

By Alan, on April 11th, 2022%

Results from a lab study show engineered immune system cells sharply reduce tumors and extend survival in mice grafted with a type of ovarian cancer. . . . → Read More: Natural Killer Cells Stop Ovarian Cancer in Preclinical Test

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise